340B Drug Pricing Program
Learn what the HHS 340B Drug Pricing Program is and what 340B hospitals are. The program allows 340B hospitals to stretch limited federal resources to reduce the price of outpatient pharmaceuticals for patients by providing 340B drug pricing discounts and expand health services to the patients and…
The CMS Nov. 4 issued a final rule that updates physician fee schedule payments for calendar year 2027.
CMS’ Medicare outpatient hospital payment rate does not adequately take into account the financial challenges facing hospitals today. These challenges are amplified for hospitals serving rural and underserved communities, many of which are already making hard decisions about how they will maintain…
The AHA Oct. 27 submitted comments on the Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future of 340B Act (SUSTAIN 340B Act).
The AHA yesterday submitted comments on the Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future of 340B Act (SUSTAIN 340B Act).
The SUSTAIN 340B Act represents a constructive bipartisan effort to establish clear and durable rules for all stakeholders in the program.
Please encourage your House representatives to co-sponsor the 340B Rebate Model Delay Act (H.R. 10770), a bipartisan bill that would pause the Department of Health and Human Services 340B Rebate Model Pilot Program, currently set to go into effect Jan. 1, 2027.
Please encourage your House representatives to co-sponsor the 340B Rebate Model Delay Act (H.R. 10770), a bipartisan bill that would pause the Department of Health and Human Services 340B Rebate Model Pilot Program, currently set to go into effect Jan. 1, 2027.
AHA urges court to reject drug industry intervention in 340B rebate program case.
The U.S. District Court for the District of Maine should deny motions by several drug companies and Pharmaceutical Research and Manufacturers of America to intervene in the lawsuit challenging the administration’s revised 340B rebate model, the AHA and its co-plaintiffs argued in a filing submitted…